This activity has been designed for medical, surgical and radiation oncologists, radiologists, urologists, gastroenterologists, primary care physicians, dermatologists, pulmonologists, hematologists/oncologists, hematology/oncology fellows, oncology nurses, and other healthcare professionals involved in the treatment of patients with cancer.

Upon completion of this course, participants should be able to:

• Describe recent advances in immunotherapy for cancer treatment
• Identify the current clinical approaches to immunotherapy
• Explain how to apply new clinical findings to a broad range of tumor types
• Identify issues related to extent of therapy by genomics, stage and patient condition
• Describe optimal use of targeted agents

PHYSICIANS: The Perelman School of Medicine at the University of Pennsylvania is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

NURSES: Penn Medicine Nursing is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Approval # 124-3-H-15.

PHYSICIANS: The Perelman School of Medicine at the University of Pennsylvania designates this live activity for a maximum of 2.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSES: This program will award 2.75 contact hours.

AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 2.75 Category 1 credits for completing this activity.

Disclosures

The Perelman School of Medicine at the University of Pennsylvania, Office of Continuing Medical Education, adheres to the ACCME Standards for Commercial Support. Faculty disclosure information will be made available in the conference materials and syllabus. Faculty members are also expected to disclose to participants any discussion of off-label and / or investigational use of pharmaceutical products or devices with in their presentations.

Course Chairs Perelman School of Medicine 

Kevin R, Fox, MD
Marian T. and Robert J. MacDonald Professor of Medicine (Hematology/Oncology)
Director, Rena Rowan Breast Center 

Lynn M. Schuchter, MD
C. Willard Robinson Professor of Medicine (Hematology Oncology)
Chief, Division of Hematology Oncology
Program Leader, Melanoma and Cutaneous Malignancies Program  

Faculty Affiliated with the Perelman School of Medicine at the University of Pennsylvania

Charu Aggarwal, MD, MPH
Assistant Professor, Medicine (Hematology/Oncology)

Joshua M. Bauml, MD
Assistant Professor, Medicine (Hematology/Oncology)

Angela M. DeMichele, MD, MSCE
Alan and Jill Miller Professor in Breast Cancer Excellence (Hematology/Oncology)

Tara C. Gangadhar, MD
Assistant Professor, Medicine (Hematology/Oncology)

Maureen R. Hewitt, MD
Penn Medicine Clinician (Hematology/Oncology)

Corey J. Langer, MD, FACP
Professor, Medicine (Hematology/Oncology)

Gerald P. Linette, MD, PHD
Clinical Associate, Medicine (Hematology/Oncology)
Chief Medical Officer for Cancer Immunotherapy
Clinical Director, Sean Parker Institute 

Anthony R. Mato, MD
Assistant Professor of Medicine (Hematology/Oncology)

David M. Mintzer, MD
Clinical Professor, Medicine (Hematology/Oncology)

Suzanne McGettigan, CRNP
Oncology Advanced Practice Nurse

Ursina R. Teitelbaum, MD
Deenie Greitzer and Daniel G. Haller Associate Professor, Medicine (Hematology/Oncology)

David J. Vaughn, MD
Professor, Medicine (Hematology/Oncology)